Ticker: CYTK | Published: 2026-09-23
CYTK sinks violently
The stock is falling sharply on heavy intraday swings while the broader market rallies, pointing to company-specific selling pressure likely tied to profit-taking and investor digestion of its Bernstein healthcare forum commentary on expanding beyond its first drug launch, with an insider share sale by its R&D chief adding a negative optics layer.
Sources: